Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Feb 5, 2019- As reported, revenues of $4.160 billion increased 35.1 percent.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $4.160 billion for the first fiscal quarter ended December 31,...
-
Jan 24, 2019BD Nano(TM) Second Generation Pen Needle Receives 510(k) Clearance from U.S. Food and Drug Administration
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the U.S. Food and Drug Administration 510(k) clearance of its second generation BD Nano(TM)...
-
Dec 20, 2018BD MAX(TM) Enteric Viral Panel Receives 510(k) Clearance from U.S. Food and Drug Administration
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration 510(k) clearance of its BD MAX(TM) enteric viral...
Dec 11, 2018BD FACSLyric(TM) Flow Cytometer is First BD Product to Earn UL Cybersecurity Assurance Program CertificationBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the completion of an enterprise level cybersecurity assessment from UL. This...
-
Nov 29, 2018Learn how advanced analytics can help combat a critical component of the opioid epidemic at the #ASHP18 Midyear Meeting
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of a new software application designed to help hospitals and health systems...